Table 6. Effect freezing and thawing treatment in addition ascorbic acids on sperm quality

Parameter	Motilty	Viability	Abnormality	PIM
Ascorbic acid
BF (n=35)	70.46 ± 3.79^a1)	76.40 ± 2.79^a	19.77 ± 2.06^b	70.71 ± 3.09^a
AF (n=35)	53.26 ± 3.04^b	60.51 ± 2.79^b	26.37 ± 2.40^a	60.68 ± 2.78^b
Δ BF–AF	17.02 ± 0.82	15.89 ± 0.67	−6.60 ± 0.53	10.03 ± 0.70
Lycopene
BF (n=35)	68.09 ± 3.84^a	74.14 ± 2.66^a	18.63 ± 2.03^b	68.77 ± 3.25^a
AF (n=35)	51.85 ± 4.83^b	58.31 ± 2.62^b	24.37 ± 2.40^a	59.09 ± 2.64^b
Δ BF–AF	16.23 ± 1.0	15.83 ± 0.63	−5.74 ± 0.53	9.69 ± 0.71

Data show all mean ± standard error of means (n = 7)
Means in a column with different superscripts differ significantly at p < 0.05.
PMI, plasma membrane integrity; BF, data before freezing treatment; AF, data after thawing treatment.